1. Luo M, Zhang WW, Deng CF, Tan QS, Luo C, Luo S. Advances in studies of medicinal crop Polygonatum cyrtonema Hua. Lishizhen Med Mater Med Res. 2016;27(6):1467–9.
2. Committee for the Pharmacopoeia of People Republic China. Pharmacopoeia of P.R. China, part I: Chinese Pharmacopoeia, edition one. 2020. p. 319–20. https://db.ouryao.com/yd2020/.
3. Chen H, Feng SS, Sun YJ, Hao ZY, Zheng XK. Advances in studies on chemical constituents of three medicinal plants from Polygonatum mill. and their pharmacological activities. Chin Tradit Herb Drugs. 2015;46(15):2329–38.
4. Yang JX, Wu S, Huang XL, Hu XQ, Zhang Y. Hypolipidemic activity and antiatherosclerotic effect of polysaccharide of Polygonatum sibiricum in rabbit model and related cellular mechanisms. Evid Based Complement Altern Med. 2015;39:1065.
5. Wu LH, Lv GY, Li B, Zhang YL, Su J, Chen SH. Study on effect of Polygonatum sibiricum on Yin deficiency model rats induced by long-term overload swimming. China J Chin Mater Med. 2014;39(10):1886–91.